AlphaYouMB
Insider selling
Matthias Bodenstedt sold $352K of MoonLake Immunotherapeutics (MLTX) stock
Matthias Bodenstedt, Chief Financial Officer of MoonLake Immunotherapeutics (MLTX), sold 17,876 shares of MLTX stock worth $352K, per an SEC Form 4 filed Jun 18, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 17, 2026, 1 day before it was made public.
MLTX has moved -34.6% since the trade date, from $19.19 to $12.55 (Sep 21, 2026 close).
- Traded
- Jun 17, 2026
- Disclosed
- Jun 18, 2026
- Filing delay
- 1 day
- Price since
- -34.6%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More MLTX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.